Renaissance Technologies LLC Decreases Stake in Seer, Inc. (NASDAQ:SEER)

Renaissance Technologies LLC reduced its holdings in Seer, Inc. (NASDAQ:SEER) by 46.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 502,700 shares of the company’s stock after selling 439,300 shares during the period. Renaissance Technologies LLC owned approximately 0.78% of Seer worth $845,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Brandywine Managers LLC bought a new position in Seer in the 4th quarter worth about $86,000. Syon Capital LLC purchased a new position in shares of Seer in the 4th quarter valued at about $94,000. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Seer during the 1st quarter worth approximately $35,000. Marquette Asset Management LLC lifted its stake in Seer by 24.9% in the 1st quarter. Marquette Asset Management LLC now owns 61,510 shares of the company’s stock valued at $117,000 after buying an additional 12,246 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in shares of Seer by 13.0% during the first quarter. Russell Investments Group Ltd. now owns 94,868 shares of the company’s stock worth $180,000 after purchasing an additional 10,951 shares in the last quarter. Institutional investors own 75.20% of the company’s stock.

Seer Price Performance

Seer stock opened at $1.94 on Tuesday. The stock’s fifty day moving average is $1.75 and its two-hundred day moving average is $1.82. Seer, Inc. has a 1-year low of $1.46 and a 1-year high of $2.30. The stock has a market cap of $125.66 million, a PE ratio of -1.47 and a beta of 1.46.

Seer (NASDAQ:SEER) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.35) EPS for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.01. The firm had revenue of $3.07 million during the quarter, compared to the consensus estimate of $3.33 million. Seer had a negative net margin of 559.21% and a negative return on equity of 21.26%. During the same quarter last year, the firm earned ($0.37) earnings per share. On average, research analysts expect that Seer, Inc. will post -1.27 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Morgan Stanley reduced their price target on shares of Seer from $7.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 13th.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.